eMedicine Specialties > Neurology > Neuro-imaging
PET Scanning in Autism Spectrum Disorders
Updated: Nov 1, 2010
Introduction
This article addresses the body of research concerning autism spectrum disorders and other pervasive developmental disorders. While positron emission tomography (PET) scanning has contributed to the knowledge about autism spectrum disorders, the procedures described in this article are research protocols. PET scanning and other nuclear medical procedures are not indicated in the diagnosis and treatment of autism spectrum disorders and other pervasive developmental disorders. Currently, PET scanning and other nuclear medical procedures are not indicated for the evaluation of individuals who may have autism spectrum disorders and other pervasive developmental disorders.
Autistic disorder is a class of pervasive developmental disorders that present in early childhood and are characterized by marked abnormalities in language, communication, and social interactions and by a restricted and peculiar range of interests and activities. The male-to-female ratio of patients with autistic disorder is approximately 3-4:1. Most people with autistic disorder also exhibit mental retardation and approximately one third of people have seizure disorders.
Complications in the prenatal, perinatal, and postnatal periods have been decsribed in some cases of autism and other pervasive developmental disorders.1,2,3 Exposure to toxins, poisons, residues, and other contaminants is one of the mechanisms hypothesized to cause autism and related conditions. While evidence exists that toxic exposure may play a role in isolated cases of autism, no convincing evidence that toxic exposure is instrumental in the causation of autism in the population in general has been reported. In particular, anecdotal reports that autism developed in children who received immunization to measles, mumps, and rubella have not been confirmed in the general population. Thus, immunization is not associated with the development of autism in general. For this reason, routine immunizations, including immunization for measles, mumps, and rubella, are recommended for the general population.
Autism spectrum disorders include autistic disorder, Asperger disorder, Rett disorder, childhood disintegrative disorder, and other pervasive developmental disorders. For additional information about autistic disorder, please refer to the article Pervasive Developmental Disorder: Autism in the Pediatrics journal. For additional information about Asperger syndrome, please refer to the article Pervasive Developmental Disorder: Asperger Syndrome in the Pediatrics journal.
Autism spectrum disorders include pervasive developmental disorders not otherwise specified. Thus, autism spectrum disorders include autistic disorder as well as conditions with some features of autistic disorder and without all criteria required for autistic disorder. Autistic disorder is probably a heterogeneous condition with multiple causes, some of which are unknown.
A major concern in the interpretation of reports about positron emission tomography (PET) scans in autism spectrum disorders is the accuracy and the precision of the diagnoses. The widely used systems of nomenclature, including the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)4 and the International Classification of Diseases, Ninth Revision, Clinical Modification, Fourth Edition (ICD-9-CM)5 list criteria for several autism spectrum disorders.
While both DSM-IV-TR and ICD-9-CM contain criteria for various autism spectrum disorders, those criteria are listed in an outline fashion that challenges inexperienced readers. Those who are expert in autism spectrum disorders know what the terms of DSM-IV-TR and ICD-9-CM mean. On the other hand, the sketchy descriptions of both DSM-IV-TR and ICD-9-CM are prone to misinterpretation by inexperienced readers. Therefore, attempts by inexperienced individuals to diagnose autism spectrum disorders by the application of criteria from DSM-IV-TR and ICD-9-CM are fraught with error.
Specialized diagnostic procedures have been developed for autistic disorder and other autism spectrum disorders. The diagnostic tools for autism spectrum disorders require training in order to attain a reliable administration. The detailed description of the procedures to diagnosis autistic disorder and other autism spectrum disorders is beyond the scope of this article. Please refer to the articles Pervasive Developmental Disorder: Autism and Pervasive Developmental Disorder: Asperger Syndrome in the Pediatrics journal for suggestions about screening for these conditions in clinical and research settings. When in doubt about the possible presence of autism spectrum disorders, please refer the individual to a clinician experienced in the diagnosis of autism spectrum disorders for a definitive evaluation.
Clinical symptoms of autism spectrum disorders include problems with social interaction, problems in making friends, and limited nonverbal communication. Since social deficits are a hallmark of autism spectrum disorders, researchers are investigating the nature of nonverbal communications, including facial recognition and interpretation of affect exhibited by facial expressions. The understanding of hand gestures and eye gaze provides crucial clues about the feelings and intentions of others. Persons with autism spectrum disorders exhibit deficits in facial perception. Instead of identifying people on the basis of overall facial configuration, persons with autism spectrum disorders use the lower face, the mouth, and other specific portions of the face to identify others. Thus, people with autism spectrum disorders actually may identify the faces of people by focusing on the objects that form the face rather than the whole person.
Megalencephaly has been reported in a few cases of autistic disorder. Thus, a subset of individuals with autistic disorder may be characterized by this finding.
The cerebella of some individuals with autistic disorder demonstrate hypoplasia while others demonstrate hyperplasia. Additionally, oculomotor studies have provided evidence of neocortical dysfunction of the prefrontal cortex and connections to the parietal lobe. Separate subgroups with neocortical dysfunction and others with cerebellar dysfunction may exist.
Perception is accomplished in the brain by means of a parietal pathway for spatial and motor function and a temporal pathway for identification of objects, faces, and gestures. Anomalies in the amygdala and other structures of the medial temporal lobe have been demonstrated repeatedly in autism spectrum disorders, suggesting involvement of the temporal pathway for visuoperceptual processing. Functional magnetic resonance imaging (fMRI) of people with autism spectrum disorders demonstrates reduced activation in the fusiform gyrus, the portion of the brain associated with facial recognition, and increased activation of adjacent portions of the brain associated with recognition of objects. fMRI also suggests that, in some individuals with Asperger syndrome and high-functioning autism, dysfunctional connections among limbic and paralimbic regions, the cerebellum, and the extrastriate visual cortices occur during the process of identification of the emotion expressed by faces and the gender of the face.
Rett syndrome is a pervasive developmental disorder presenting in early childhood primarily in girls. Children with Rett syndrome exhibit normal development in the first year of life. They typically fail to attain milestones between ages 1 and 6 years. They exhibit profound mental retardation and typically require assistance in the activities of daily living. Almost all individuals with Rett syndrome display abnormalities of the Methyl-CpG-Binding Protein 2 (MeCP2) gene.6 For additional information, please refer to the article Pervasive Developmental Disorder: Rett Syndrome in the Pediatrics journal.
A variety of personal and clinical data is relevant to the analysis of studies of individuals with autism spectrum disorders. Specifically the presence of claustrophobia or scoliosis may interfere with the ability to hold still for scans. Additionally the use of nicotine, caffeine, alcohol, and drugs may have short-term and long-term effects on the brain so current and past use of substances is relevant. The presence of other medical, neurological, psychiatric, and psychological conditions may affect the scans of the individual. Therefore, knowledge of all current and prior physical and emotional disorders is crucial.
The history of a suicide attempt is important because subjects experience both physical and psychological stress before, during, and after scans. Individuals who are acutely suicidal merit inpatient psychiatric hospitalization. Generally, subjects who are suicidal are not appropriate for scans for research purposes. The special needs of research on suicide are beyond the scope of this article.
In order to obtain relevant screening information on all potential research subjects, we have prepared a Questionnaire for Subjects (see Image 9 for a printable version). The Questionnaire for Subjects can be sent to individuals as part of the screening process.
Potential subjects for research studies can be excluded from further participation if the presence of exclusionary criteria is identified on review of the Questionnaire for Subjects. For clinical studies, the presence of positive findings on the Questionnaire for Subjects indicates the need for tailoring the future studies to the needs and limitations of the individual.
After review of the Questionnaire for Subjects confirms that the person is suitable for further evaluation, then a medical history and physical examination must be accomplished before nuclear studies are performed. Additionally, rigorous recording of demographic data7 , including ethnicity8 , is crucial to the accurate characterization of clinical patients and research subjects for clinical, research, administrative, and educational purposes. Structured interviews, using a Nuclear Medical History Recording Form (see Image 10 for a printable version) and examinations, using the Nuclear Medical Physical Examination Recording Form (see Image 11 for a printable version) are helpful to verify that an adequate assessment has been obtained for nuclear medical procedures.
Typically, research subjects have few findings on medical history and physical examination. The presence of positive findings on medical history and physical examination indicates the need to verify the absence of exclusionary criteria for research studies. Also, the presence of positive findings on medical history and physical examination indicates the need for consideration of possible contraindications for clinical studies. The needs and limitations of each individual must be considered before proceeding with nuclear studies.
Because the findings in the brains of people with autism and related conditions may be lateralized, identification of the lateral preferences of the subject is a crucial component of the examination of each subject. Denckla developed a quick procedure, suitable for clinical settings, that is used to identify the lateral preferences for the use of the eye, the hand, and the foot in children, adolescents, and adults.9 Before scans of the brain are performed, the Lateral Preferences Examination Form (see Image 12 for a printable version) is completed for all subjects to identify the preferred side for the eye, the foot, and the hand.
The examiner scores the Lateral Preferences Examination in vivo. In addition to the live rating by the examiner, the Lateral Preferences Examination is videotaped for later blind rating by experts unfamiliar with the status of the subject. The blind videotape rating of the Lateral Preferences Examination is useful to determine reliability of the live ratings of the exam.
Additionally, blind rating of the videotape of the Lateral Preferences Examination is useful to protect against any left-right dissociation in the examiner. Examiners may experience confusion themselves in determining the side used by the subjects for each task. Therefore, rating of videotaped assessments is a crucial component of research studies of scans of the brain.
For related information, see Medscape's Autism Resource Center.
Positron Emission Tomography
PET is a functional imaging technique that visualizes physiological structures in relation to events, such as performance of activities and administration of chemical agents. PET is used as a tool that provides images of the brain after administration of radioligands.
PET also permits mapping of receptors throughout the body. This is particularly important with regard to autism spectrum disorders because PET can identify receptors for specific neurotransmitters in vivo. Evidence exists that some groups of individuals with autism spectrum disorders have dysfunction of serotonin, dopamine, nicotine, and other neurotransmitters in portions of the CNS. PET is a tool for assessing the function of receptors for serotonin and other neurotransmitters throughout the brain. These findings are important because they provide clues to novel therapeutic interventions.
PET is used in the study of other diseases as well. Other uses of PET include measurement of regional cerebral glucose metabolism. PET with 18-fluoro-2-deoxyglucose has demonstrated interictal temporal hypometabolism consistent with marked improvement after surgical treatment in patients with partial seizures with complex symptomatology. PET with 18-fluoro-deoxyglucose is also useful in identifying malignant growths in the brain, other portions of the CNS, and other parts of the body.
PET to Characterize Metabolism in Autistic Disorder
PET has demonstrated multiple deficits in individuals with autism. No single finding has characterized all people with autism. The results have varied from individual to individual.
With 18-fluoro-2-deoxyglucose (FDG), the anterior rectal gyrus has been found to be larger on the left side than the right side in some people with autistic disorder, a finding opposite to the asymmetry seen in healthy individuals. Some people with autistic disorder also exhibit increased glucose metabolic rate in the right posterior calcarine cortex and decreased glucose metabolic rate in the medial frontal region, left posterior putamen, and left medial thalamus. Simultaneous correlation of the structures on PET and MRI has established that the right anterior cingulate gyrus is smaller and metabolically less active in a small group of high-functioning adults with autism.
For example, the following image were obtained approximately 30 minutes after intravenous (IV) administration of 4.15 mCi of FDG to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Please refer to the article Pervasive Developmental Disorder: Autism in the Pediatrics journal for further clinical information about this patient. He is illustrated in several videotape segments of that article.
The following image demonstrates axial sections from superior to inferior; the left side of the figure corresponds to the right side of the patient.
This picture was obtained approximately 30 minutes after intravenous administration of 4.15 mCi of 18-fluoro-2-deoxyglucose to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Coronal sections are shown from anterior to posterior; the left side of the figure corresponds to the right side of the patient. Courtesy of Rashid A Fawwaz, MD, PhD, The Kreitchman PET Center, Columbia-Presbyterian Medical Center, New York, NY.
The following image demonstrates coronal sections from anterior to posterior; the left side of the figure corresponds to the right side of the patient.
This picture was obtained approximately 30 minutes after intravenous administration of 4.15 mCi of 18-fluoro-2-deoxyglucose to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Axial sections are shown from superior to inferior; the left side of the figure corresponds to the right side of the patient. Hypometabolism, greater on the left than the right, is demonstrated in the temporal and parietal regions. This is particularly prominent in the third and fourth images. Courtesy of Rashid A Fawwaz, MD, PhD, The Kreitchman PET Center, Columbia-Presbyterian Medical Center, New York, NY.
The following image demonstrates sagittal images of the patient from right to left. Hypometabolism, greater on the left than the right, is demonstrated in the temporal and parietal regions. This is particularly prominent in the third and fourth depictions in the first image above.
This picture was obtained approximately 30 minutes after intravenous administration of 4.15 mCi of 18-fluoro-2-deoxyglucose to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Sagittal images are seen from right to left. Courtesy of Rashid A Fawwaz, MD, PhD, The Kreitchman PET Center, Columbia-Presbyterian Medical Center, New York, NY.
These findings suggest functional bases for the abnormalities in assessing environmental visual and emotional cues. Reversal in the size of the anterior rectal gyrus and reversal of hemispheric dominance for language in some people with autistic disorder suggest possible bases for the social, emotional, and language deficits.
In people with tuberous sclerosis and autistic disorder, scans with FDG demonstrate that glucose metabolism is decreased bilaterally in the lateral temporal gyri and increased bilaterally in deep cerebellar nuclei.
Chugani and colleagues have reported that FDG-PET characterizes a group of children with evidence of autism and unilateral facial port-wine stains. FDG-PET scans differentiate children with autism and facial port-wine stains from children with autism without facial port-wine stains. In children with autism and facial port-wine stains, decreased metabolism on FDG-PET was observed bilaterally in the medial temporal regions, the frontal cortices, the anterior cingulate gyri, the cerebellum, and the right temporal cortex. In contrast, children with autism without facial port-wine stains showed decrements in metabolism on FDG-PET that were mild in the left medial temporal regions and more pronounced in the right temporal cortices. Furthermore, children with autism without facial port-wine stains showed reversals of the normal frontal temporal asymmetry in metabolism on FDG-PET. These observations of a small sample of patients await confirmation by other groups.10
PET of the Serotonergic System in Autism Spectrum Disorders
Serotonin metabolism in autistic disorder
Evidence is mounting that abnormalities of serotonin metabolism play an important role in individuals with autism spectrum disorders. Whole-blood serotonin often is elevated in children with autistic disorder and normal intelligence. Also, in boys with autistic disorder, serotonin synthesis typically is decreased in the frontal region and thalamus on one side of the brain and increased in the dentate nucleus of the opposite cerebellum. Therefore, serotonin synthesis appears to vary distinctly in subgroups of people with autistic disorder that are based on sex and intelligence.
Elucidation of the role of serotonin in development and maintenance of the symptoms and signs of autistic disorder will facilitate development of treatments targeted to correct the specific deficits of each subtype, including gene transfer strategies. The fact that one third of people with autistic disorder demonstrate elevated blood serotonin levels gives reason to suspect that some people with autistic disorder or other pervasive developmental disorders may have abnormalities in the serotonergic pathways in the brain and other parts of the body. Chugani reviewed the evidence for anomalous development of the serotonin system in the brain in autism.11
Considerable evidence indicates that abnormalities in the metabolism of serotonin in the brain characterize a large group of individuals with autistic disorder. The value of clarification of the nature of the serotonergic dysfunction has been recognized; however, most prior studies have indirectly used peripheral serotonin measures (eg, blood, urine) that are not associated consistently with the diagnosis of autistic disorder.
Further evidence suggests that serotonin receptors and transporters do not function properly in individuals with autism. Elucidation of anomalies in the functioning of serotonin transporters and receptors in autistic disorder will form the basis of specific therapy targeted to meet identified deficits. Evidence from multiple sources suggests that dysfunctions of serotonin receptors and transporters characterize distinct biologic classes of individuals with autism spectrum disorders.
Recently, PET has been employed to suggest the function of portions of the brain associated with the deficits observed through neurophysiological and neuropsychological examination. However, quantitative interpretation of this method has not been confirmed.
Alpha-[11 C]methyl-L-tryptophan (AMT), a tracer for measuring the synthesis of serotonin, has been used with PET. Studies using PET after administration of AMT, primarily of children with autistic disorder, have demonstrated striking anomalies of serotonin synthesis in boys. Children with autism demonstrate several patterns of abnormal cortical development, including the left cortex and the right cortex. Left cortical AMT decreases in children with autism are associated with marked language disorders.12
Serotonin dysfunction in comorbid disorders
Evidence to support the hypothesis that serotonin dysfunction causes some cases of autistic disorder comes from studies of the neurophysiology of other disorders commonly encountered in people with autistic disorder, including mood disorders, Tourette disorder, and obsessive-compulsive disorder. Dysregulation of serotonin metabolism is implicated in the pathogenesis of major depression and obsessive-compulsive disorder. The rates of depression, obsessions, and compulsions often are increased in populations of individuals with autistic disorder.
Some individuals with Tourette disorder have evidence of dysfunction of transmission of dopamine and serotonin. Dysregulation of serotonin in the subthalamus has been suggested in some studies of Tourette disorder. Interaction of abnormal functions of the dopaminergic and serotonergic systems may contribute to Tourette disorder.
Role of serotonin in development of affiliation and cognition
Multiple aspects of growth, including affiliation and cognition, are hypothesized to depend on serotonin during development. Affiliate behaviors in animals, including humans, appear to depend on serotonin, the interaction of serotonin and opioid peptides, and the neurohypophyseal hormones oxytocin and vasopressin. Several lines of evidence in animals and humans suggest that serotonin is crucial to development and maintenance of normal affiliate behaviors. Additional evidence suggests that serotonin regulates development and function of the brain and that disrupted development of the serotonin system leads to autistic disorder and mental retardation. Adequate serotonin appears crucial early in development.
Failure to experience normal social interactions in infancy and childhood may prevent development of normal socialization at later stages of life, as in rats. Thus, during a critical period in gestation, infancy, and early childhood, the presence and effects of serotonin may be crucial for development of social skills in humans. Inadequate stimulation of serotonin to portions of the human brain early in life may create abnormalities of regulation of serotonin metabolism that cannot be corrected later. Thus, dysregulation of serotonin metabolism may be permanent in the brains of people deprived of necessary serotonin influences at key stages of early development. Furthermore, facilitation of serotonin appears to promote social confidence and the ability to relate to others. Therefore, persuasive evidence indicates that serotonin exerts a key role early in life on portions of the brain necessary for development of affiliation and cognition.
Peripheral serotonin abnormalities in autistic disorder
Elevated levels of whole-blood serotonin consistently have characterized a group of approximately one third to two thirds of individuals with autistic disorder and their parents and siblings, despite ethnic variations. However, some samples of children with autistic disorder have demonstrated decreased serotonin uptake. The presence of a familial deficit in serotonin metabolism is suggested further by the finding that parents of autistic children who themselves (the parents) have elevated whole-blood serotonin levels also have more depression, obsessions, and compulsions. The recent demonstration of hyperserotonemia in children with autistic disorder without mental retardation and hyposerotonemia in children with mental retardation without autistic disorder raises the possibility that peripheral serotonin levels in autistic disorder may vary according to levels of intelligence of the subjects.
This finding suggests that children with autistic disorder with mental retardation may be biologically distinct, in terms of dysfunction of the serotonin system, from children with autistic disorder without mental retardation. Reduction of serum tryptophan to large neutral amino acid ratios characterizes a group of children with autistic disorder, suggesting decreased availability of brain tryptophan, which is a precursor of serotonin. A tripeptide that stimulates uptake of serotonin into platelets has been demonstrated in the urine of almost two thirds of a sample of children with autism.
Decreased central serotonin binding due to antibodies to central serotonin (5-HT1A) receptors and decreased central serotonergic response have been proposed as mechanisms that mediate hyperserotonemia in some individuals with autistic disorder. However, autoantibodies against 5-HT1A receptors were not demonstrated in a small group of children with autism. General serotonin receptor binding, without determination of serotonin receptor subtype, is inhibited by the plasma of children with autistic disorder without mental retardation but is not inhibited by the plasma of children with mental retardation without autistic disorder or by the plasma of children with typical development. These findings are apparently due to the presence of blocking antibodies and not to high plasma concentrations of serotonin. Therefore, serotonin may trigger a B-cell–mediated autoantibody response to the serotonin receptor in children with autistic disorder.
The contribution of antiserotonin receptor antibodies to the symptomatology of autistic disorder is suggested by the motor inhibition seen in mice treated with antiserotonin antibodies. Although several studies have used the resemblance of serotonin type 2A receptors in human platelets and in the human frontal cortex to indirectly infer the existence of dysfunction of frontal cortical serotonin 2A receptors from the elevations of whole-blood serotonin levels in groups of people with autistic disorder, a recent study assessing serotonin type 2A receptors in the platelets and the brains of the same individuals found no correlation. When using PET after administration of [18 F]setoperone to measure central serotonin type 2A receptors and [3 H]lysergic acid diethylamide to measure serotonin type 2A receptors on the platelets of 12 healthy volunteers, no correlation between binding potentials was found in any one individual.
These recent results challenge the assumption that peripheral platelet serotonin type 2A receptors can be used to represent those in the brains of living human beings.
Positron emission tomography studies
Impairment of dentatothalamocortical pathways has been indicated in people with autism by use of PET after administration of AMT. Seven boys and one girl with autistic disorder and 5 of their nonautistic siblings were studied after administration of AMT. Asymmetries were observed in all boys with autistic disorder but not in the girl with autistic disorder. Five boys with autistic disorder demonstrated decreased serotonin synthesis in the left frontal cortex and the left thalamus and increased serotonin synthesis in the dentate nucleus of the right cerebellum. The other 2 boys with autistic disorder demonstrated decreased serotonin synthesis in the right frontal cortex and the right thalamus and increased serotonin synthesis in the dentate nucleus of the left cerebellum.
In contrast with their 5 nonautistic siblings, the 7 boys with autistic disorder demonstrated statistically significant asymmetry indices for the frontal cortex, the thalamus, and the dentate nucleus combined and separately for the frontal cortex and the thalamus.
A subsequent study of PET after administration of AMT to 9 girls with autistic disorder revealed asymmetry of frontal cortical synthesis in the 4 girls without mental retardation but not in the 5 girls with mental retardation (P = .003). Heterogeneous cerebellar anomalies were observed in 3 of the 4 girls with frontal asymmetries. These studies suggest that girls with autistic disorder without mental retardation may exhibit dysregulation of serotonin metabolism similar to boys with autistic disorder, while girls with autistic disorder with mental retardation may have different frontal serotonin metabolism. Thus, PET studies of serotonin synthesis in autistic disorder suggest that serotonin metabolism in autistic disorder varies biologically according to sex and intelligence.
A subsequent study using AMT confirmed the earlier findings of atypical serotonin synthesis in children, adolescents, and adults with autistic disorder. Thirty children with autistic disorder, 8 of their siblings, and 16 children with epilepsy were evaluated after administration of AMT. This sample included the 8 children with autistic disorder and their 5 siblings described in the previous paragraph. Children aged 2-5 years with typical development exhibited higher serotonin synthesis than that exhibited by adults; as children grow, the serotonin synthesis gradually declines to adult values. The decline to adult values occurs earlier in girls than in boys. In contrast, boys, but not girls, with autistic disorder exhibit decreased focal serotonin synthesis in the frontal cortex and thalamus at all ages.
Chandana and colleagues used AMT to study 117 children with autism to find groups with left cortical abnormalities, with right cortical abnormalities, and without abnormal cortical asymmetries.12 Children with left cortical AMT decreases showed severe language impairments. Children with right cortical AMT decreases showed more left and mixed handedness.
((11)C)-labeled trans-1,2,3,5,6,10-beta-hexahydro-6-[4-(methylthio)phenyl]pyrrolo-[2,1-a]isoquinoline ([(11)C](+)McN-5652), a radioligand for the serotonin transporter, was administered to 20 men with autism and 20 age-matched and IQ-matched controls. The uptake throughout the brain was significantly lower in the group with autism. Impaired social cognition was correlated with reductions of the serotonin transporter in the anterior and posterior cingulate cortices of the men with autism.13 These findings suggest the presence of dysfunction of the serotonergic system in a subset of people with autism. The study requires replication with different larger samples in various geographic locations.
Whole-brain serotonin synthesis is decreased in both boys and girls with autistic disorder as compared to children with typical development, and it gradually increases with age to values 1.5 times greater than those of adults with typical development. In adults with typical development, serotonin synthesis is higher in women than in men. However, inaccuracies are likely because of the failure to employ partial volume corrections to compensate for ventricular enlargement and atrophy or inadequate development reported in the corpus callosum, cerebellum, temporal lobes, and parietal lobes of some individuals with autistic disorder. The partial volume correction is likely to be important because of the unreliability of manually outlining portions of MRIs.
Treatment studies with serotonergic agents
Dysfunction of central serotonin receptors and transmitters in some individuals with autistic disorder, possibly through interactions with central glutamate pathways, is suggested by reports of beneficial effects of medications that increase central serotonin, such as 5-HT2A receptor antagonists. However, treatment with serotonergic agents is not consistently beneficial for serious symptoms of autistic disorder, such as self-injury. The symptom provocation strategy of acute depletion of brain serotonin induced by a tryptophan-poor amino-acid load worsened symptoms in a group of adults with autistic disorder, possibly by reducing serotonin levels in the brain.
Hypersensitivity of serotonin type 1D receptor in autistic disorder is suggested by the greater growth hormone response and increase of repetitive behavior of a small sample of adults with autistic disorder treated with sumatriptan, a serotonin type 1D agonist, as compared to placebo. Furthermore, development of serotonin transporter regulatory agents may result in new therapies targeted at specific deficits of serotonin metabolism of a group of people with autism.
Serotonin in sleep abnormalities of autistic disorder
Additional evidence pointing to dysregulation of serotonin metabolism in autistic disorder includes the likely pathophysiology of the sleep abnormalities in people with autistic disorder.
Genetic evidence for serotonin anomalies in autistic disorder
A strong genetic etiology probably exists for many cases of autistic disorder. Genetic studies provide evidence for the association between serotonin transporter and autistic disorder. A study of a German sample of people with autism spectrum disorders revealed higher frequency and preferential transmission of the long allele of a common polymorphism, the serotonin transmitter gene-linked polymorphism region, in the upstream regulatory region of the serotonin transporter. However, another study with an international sample of subjects demonstrated no association of the serotonin transporter gene and autistic disorder. Another study did not confirm the association of the serotonin type 7 receptor with autistic disorder. Ethnic differences in study populations may account for some of the discrepancies between study results.
Use of PET after administration of AMT facilitates identification of alterations in metabolism of serotonin in the brains of persons with autistic disorder and related conditions.
Gross abnormalities have been detected by visual inspection of PET scans of boys with autistic disorder after administration of AMT. Most boys with autistic disorder display decreased accumulation of AMT in the left frontal cortex and left thalamus and elevated accumulation of AMT in the right dentate nucleus of the cerebellum. A minority of boys with autistic disorder display a pattern of accumulation of AMT that is the mirror image of the pattern seen in the majority of boys with autistic disorder, ie, they have decreased accumulation of AMT in the right frontal cortex and the right thalamus and elevated accumulation of AMT in the left dentate nucleus of the cerebellum. In addition, the brother of a boy with autistic disorder was a calendar calculator who lined up his toys ritualistically and demonstrated increased accumulation of AMT in the right dentate nucleus of the cerebellum.
Since deficits of the frontal lobes often are manifested by problems in executive functioning, these findings suggest a physiological basis for the problems of interpreting and initiating social interactions. In addition, anomalous thalamic findings indicate a functional source for the problems with analyzing environmental stimuli and performing appropriate responses. The anomalies in the dentate nucleus may provide the explanation for the clumsiness and other coordination problems of some boys with autistic disorder. Furthermore, the findings suggest a deficiency in the pathway connecting the affected frontal lobe with the ipsilateral thalamus and the contralateral cerebellum. Thus, altered serotonergic metabolism in the dentatothalamocortical pathways may be a pathophysiological mechanism of autistic disorder in some boys.
In people with tuberous sclerosis and autistic disorder, scans with AMT demonstrate increased uptake bilaterally in the caudate nuclei.
PET With a Dopamine Transporter Probe in Rett Disorder
The dopamine transporter ligand beta-carbomethoxy-3 beta-4-fluorophenyl tropane (CFT) has been used to study patients with Rett disorder and healthy control subjects. Patients with Rett disorder demonstrate reduction in the binding potential of CFT in the caudate and the putamen.
While one group of researchers using PET after administration of N-(11 C) methylspiperone (NMS) found low normal values of receptor density of postsynaptic D2-like dopamine receptors in the caudate of subjects with Rett disorder, other researchers using single-photon emission computed tomography (SPECT) after administration of (123 I)iodolisuride found increased specific binding of this radiotracer to the D2-like dopamine receptor in subjects with Rett disorder.13 These results suggest dysfunction in dopamine transport in the caudate and putamen of people with Rett disorder. These findings provide a basis for explaining the abnormal movements and postures observed in these subjects.
The discrepancies among the groups suggest that Rett disorder has heterogeneous causes and manifestations. Increased and decreased dopamine-receptor binding may characterize different classes of subjects with Rett disorder. Alternatively, dopamine receptor binding may change at different stages in the progression of Rett syndrome. Another explanation is that different findings may result from the specific protocols, including radiotracers, used by the research groups.
Other PET Studies
Regional cerebral blood flow (rCBF), dopamine synthesis rate, and dopamine D2 receptor binding were assessed in 6 children aged 3-5 years utilizing [15 O] water (12 MBq/kg), L-(11 C)DOPA (6 MBq/kg), and NMS (4 MBq/kg), respectively. The children were treated with 6R-L-erythro-5,6,7,8-tetrahydrobiopterin (RBH4), a cofactor for tyrosine hydroxylase in the biosynthetic pathway of catecholamines and dopamine, at a dose of 3 mg/kg/day with twice-daily oral administrations for 12 weeks in an open fashion.
The rCBF did not differ from that of adults. L-(11 C) DOPA utilization rate and NMS binding were elevated in all subjects before treatment with RBH4. After treatment, NMS binding in the caudate was reduced by 10%, and that in the putamen was reduced by 8%. The L-(11 C) DOPA utilization rate remained unchanged. The increased dopamine D2 receptor binding seen before treatment was reduced by the therapy.
PET scans after IV administration of 25 mCi of [15 O] water as a slow bolus over 20 seconds revealed reversal of hemispheric dominance during verbal auditory stimulation, reduced auditory dominance activation during verbal auditory stimulation, and reduced cerebellar activation during nonverbal auditory perception in adults with high-functioning autistic disorder, suggesting cerebellar dysfunction and atypical dominance for language.
PET scans after IV bolus administration of 0.5 or 7 mCi of [15 O] water revealed hypoperfusion in the left, right, or both temporal lobes in children with autistic disorder.
PET scans after IV bolus administration of 300 MBq of [15 O] water revealed increasing rCBF (1) in the medial prefrontal cortex with increasing horizontal gaze aversion and (2) in the superior and medial temporal gyri with increasing direct gaze in a group of healthy women. This finding is relevant to the understanding of autism spectrum disorders because gaze is hypothesized to reflect the ability to detect the mental states of others. People with high-functioning autism, Asperger syndrome, and related autistic spectrum disorders frequently demonstrate impaired ability to comprehend the mental states of others. The ability to understand the mental states of others has been termed the ability to formulate a theory of mind.
The deficits in formulating a theory of mind for others have been further investigated by PET scans after IV bolus administration of [15 O] water to adults with high-functioning autism or Asperger syndrome and to healthy volunteers while watching aminated sequences. While both groups identified random and goal-directed movements, the subjects with high-functioning autism or Asperger syndrome displayed impaired ability to interpret interactions among moving figures with implied intentions. PET scans during the animations with implied intentions demonstrated more activation in the medial prefrontal cortex, the superior temporal sulcus at the temporoparietal junction, and the temporal poles in the healthy adult volunteers than in the subjects with high-functioning autism or Asperger syndrome.
While increased activation in the extrastriate region was present in both groups during the animations with implied intentions, people with high-functioning autism or Asperger syndrome had reduced functional connectivity between the extrastriate region and the superior temporal sulcus at the temporoparietal junction. These results suggest a neuroanatomical hypothesis for the impaired ability of people with high-functioning autism and Asperger syndrome to recognize the mental states of others.
Brain Scans in Autism Disorder
The rCBF is estimated by radioisotope brain imaging. Hexamethylpropyleneamine oxide (HMPAO), a lipophilic agent, typically is labeled with technetium Tc 99m. Deficits have been demonstrated in individuals with autistic disorder; however, no anomaly has been found consistently. Some people with autistic disorder have exhibited reduced rCBF in the vermis, cerebellar hemisphere, thalami, basal ganglia, and parietal and temporal lobes. These abnormalities may be clarified by future studies to identify biological subgroups.
Multimodal Imaging in Autistic Disorder
While PET scans are useful to identify regional cerebral metabolism and the distribution of neuroreceptors, they do not provide a comprehensive picture of cerebral functioning in people with autism spectrum disorders. For a thorough evaluation, multimodal imaging, ie, assessment of cerebral function through nuclear, radiological, electrophysiological, and other techniques simultaneously, is helpful.
PET and Radiological Imaging
Radiological techniques can broadly be divided into structural techniques to identify anatomical structures and functional techniques to identify physiological activities. Structural radiological techniques include MRI, CT, and radiography. Functional radiological techniques include functional MRI (fMRI) and magnetic resonance spectroscopy (MRS).14PET and structural imaging
A practical example of multimodal imaging is the use of a radiological procedure, such as MRI or CT and PET. MRI and CT are optimal tools to identify the anatomic structures of the brain, while PET is a good way to identify the physiology of the brain. The findings may be compared by having the subject wear a face mask with fiducial markers during both the MRI or CT scan and the PET. The mask allows subsequent coregistration of the MRI or CT scan and the PET and, thus, superimposition of the anatomic and physiological images. Coregistration is a time-consuming procedure, and error may be introduced in the attempt to superimpose images that are not identical.
The newly developed PET-CT resolves the problem of coregistration by simultaneously producing both images. The joint use of PET and radiological techniques is crucial to incorporate the strengths of both functional and structural imaging procedures. Since structural techniques demonstrate increments in the volume of both gray and white matter in people with autism15 , multimodal imaging use of both PET and structural techniques is indicated.14
PET and functional imaging
Since functional radiological procedures have identified reduced activity in the perigenual anterior cingulate cortex when performing social tasks and in the dorsal anterior cingulate cortex when performing nonsocial tasks16 , the use of both PET and other functional imaging procedures is a promising tool to understand the pathophysiology of autism spectrum disorders. Functional imaging techniques include nuclear medical procedures such as PET and single photon emission computed tomography (SPECT), as well as radiological procedures including fMRI and MRS.14
PET and Electrophysiological Imaging
Another type of multimodal imaging is the use of psychophysiological and electrophysiological measures in conjunction with PET. For example, a neurometric evaluation includes electroencephalography, visual evoked potentials, cortical auditory evoked potentials, auditory cognitive evoked potentials, and somatosensory evoked potentials. The neurometric protocol can be performed after PET evaluation to provide a view of the electrical activity of the different portions of the brain along with the physiological assessment provided by PET.
For example, the boy with autism and unspecified mental retardation illustrated by PET scans in the images in section PET to Characterize Metabolism in Autistic Disorder was evaluated by a neurometric battery also. When he was aged 8 years, an electrophysiological protocol was obtained.
The image below illustrates a page of the electroencephalogram, which demonstrates predominant theta activity. Alpha activity predominates in the posterior regions and the vertex. No paroxysmal events are noted. Shortly before his fourteenth birthday, he developed nocturnal seizures.
A page of an electroencephalogram of an 8-year-old boy with autistic disorder and unspecified mental retardation obtained in the awake resting state with the eyes closed. Theta activity predominates in this tracing. Alpha activity is predominant in the posterior regions and the vertex. No paroxysmal events are noted. Electromyographic artefacts are present in the ninth and tenth lines. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY.
The image below illustrates the neurometric quantitative electroencephalogram of this subject. The first row demonstrates diffuse low absolute power in all leads in all bands, reaching significance at the P <.05 level for delta activity on the left side at central, parietal, and posterior temporal regions. The second row demonstrates the relative power. Nonsignificant diffuse excess of theta can be observed on the anterior regions of the left hemisphere (second row). Deficits of theta and delta and an excess of alpha at the vertex, also in the second row, are significant (P <.01). The interhemispheric power asymmetry illustrated in the third row is normal. The fourth row illustrates an extremely abnormal (P <.01) bipolar frontal-temporal hypocoherence in beta activity. The interhemispheric coherence is otherwise normal (fourth row).
The quantitative electroencephalogram of an 8-year-old boy with autistic disorder and unspecified mental retardation obtained in the awake resting state with the eyes closed. Diffuse low absolute power in all leads in all bands is observed (first row). The absolute power reaches significance at the P<0.05 level for delta activity on the left side at central, parietal, and posterior temporal regions (first row). In relative power, a diffuse excess of theta activity occurs on the anterior regions of the left hemisphere, not reaching statistical significance (second row). Furthermore, a significant deficit of theta and delta activity and a significant excess of alpha activity at the vertex also can be observed (P< 0.01) in the second row. The generalized increase of beta activity reaching significance at F7, F8, and T4 probably represents muscle tension (second row). The interhemispheric power asymmetry in the third row is normal. The fourth row demonstrates extremely abnormal hypocoherence in beta activity in the bipolar frontal-temporal regions (fourth row). The interhemispheric coherence is otherwise normal (fourth row).
Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY.
The image below illustrates a normal left brainstem auditory evoked potential.
PET scanning in autism spectrum disorders. Left brainstem auditory evoked potential of an 8-year-old boy with autistic disorder and unspecified mental retardation. The tracing is normal for peak and interpeak latencies and morphology. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY.
The image below illustrates a normal right brainstem auditory evoked potential.
Right brainstem auditory evoked potential of an 8-year-old boy with autistic disorder and unspecified mental retardation. The tracing is normal for peak and inter-peak latencies and morphology. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY.
The image below illustrates normal auditory cognitive evoked potentials recorded in response to common and rare tones (P300).
Auditory cognitive evoked potentials recorded in response to common and rare tones (P300) of an 8-year-old boy with autistic disorder and unspecified mental retardation. The differences between evoked potentials to common and rare stimuli (P300) are normal. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY.
The images above illustrate a slightly abnormal neurometric electrophysiological evaluation similar to some children with learning disabilities (P <.05). These images were provided through the courtesy of E. Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, New York.
Thus, multimodal imaging of PET and neurometric electrophysiological evaluations are helpful to obtain an overall view of brain metabolism and physiology.
PET of the Dopaminergic System in Autism Spectrum Disorders
2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane ([11 C]WIN-35,428), a radioligand for the dopamine transporter, was administered to 20 men with autism and 20 age-matched and IQ-matched controls. The uptake in the orbitofrontal cortex was significantly higher in the group with autism.13 These findings suggest the presence of dysfunction of the dopaminergic system in a subset of people with autism. The study requires replication with different larger samples in various geographic locations.
Multimedia
 | Media file 1: This picture was obtained approximately 30 minutes after intravenous administration of 4.15 mCi of 18-fluoro-2-deoxyglucose to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Coronal sections are shown from anterior to posterior; the left side of the figure corresponds to the right side of the patient. Courtesy of Rashid A Fawwaz, MD, PhD, The Kreitchman PET Center, Columbia-Presbyterian Medical Center, New York, NY. |
 | Media file 2: This picture was obtained approximately 30 minutes after intravenous administration of 4.15 mCi of 18-fluoro-2-deoxyglucose to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Axial sections are shown from superior to inferior; the left side of the figure corresponds to the right side of the patient. Hypometabolism, greater on the left than the right, is demonstrated in the temporal and parietal regions. This is particularly prominent in the third and fourth images. Courtesy of Rashid A Fawwaz, MD, PhD, The Kreitchman PET Center, Columbia-Presbyterian Medical Center, New York, NY. |
 | Media file 3: This picture was obtained approximately 30 minutes after intravenous administration of 4.15 mCi of 18-fluoro-2-deoxyglucose to a 10-year-old boy with autistic disorder and unspecified mental retardation using auto-attenuation with a 24-minute acquisition period. Sagittal images are seen from right to left. Courtesy of Rashid A Fawwaz, MD, PhD, The Kreitchman PET Center, Columbia-Presbyterian Medical Center, New York, NY. |
 | Media file 4: A page of an electroencephalogram of an 8-year-old boy with autistic disorder and unspecified mental retardation obtained in the awake resting state with the eyes closed. Theta activity predominates in this tracing. Alpha activity is predominant in the posterior regions and the vertex. No paroxysmal events are noted. Electromyographic artefacts are present in the ninth and tenth lines. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY. |
 | Media file 5:
The quantitative electroencephalogram of an
8-year-old boy with autistic disorder and unspecified mental
retardation obtained in the awake resting state with the eyes
closed. Diffuse low absolute power in all leads in all bands is
observed (first row). The absolute power reaches significance
at the P<0.05 level for delta activity
on the left side at central, parietal, and posterior temporal
regions (first row). In relative power, a diffuse excess of
theta activity occurs on the anterior regions of the left
hemisphere, not reaching statistical significance (second row).
Furthermore, a significant deficit of theta and delta activity
and a significant excess of alpha activity at the vertex also
can be observed (P< 0.01) in the second
row. The generalized increase of beta activity reaching
significance at F7, F8, and T4 probably represents muscle
tension (second row). The interhemispheric power asymmetry in
the third row is normal. The fourth row demonstrates extremely
abnormal hypocoherence in beta activity in the bipolar
frontal-temporal regions (fourth row). The interhemispheric
coherence is otherwise normal (fourth row).
Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY. |
 | Media file 6: PET scanning in autism spectrum disorders. Left brainstem auditory evoked potential of an 8-year-old boy with autistic disorder and unspecified mental retardation. The tracing is normal for peak and interpeak latencies and morphology. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY. |
 | Media file 7: Right brainstem auditory evoked potential of an 8-year-old boy with autistic disorder and unspecified mental retardation. The tracing is normal for peak and inter-peak latencies and morphology. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY. |
 | Media file 8: Auditory cognitive evoked potentials recorded in response to common and rare tones (P300) of an 8-year-old boy with autistic disorder and unspecified mental retardation. The differences between evoked potentials to common and rare stimuli (P300) are normal. Courtesy of E Roy John, PhD, Neurometrician, Brain Research Laboratories, Department of Psychiatry, Bellevue Hospital Center and the New York University School of Medicine, New York, NY. |
 | Media file 9: Questionnaire for Subjects. |
 | Media file 10: Nuclear Medical History Recording Form. |
 | Media file 11: Nuclear Medical Physical Examination Recording Form. |
 | Media file 12: Lateral Preferences Examination Form. |
Keywords
autistic disorder, positron emission tomography, PET, Asperger disorder, Rett disorder, childhood disintegrative disorder, pervasive developmental disorders, autism, tuberous sclerosis, serotonin abnormalities, electroencephalogram, neurometric electrophysiological evaluation, Asperger syndrome, autism spectrum disorders
This research is supported by the Essel Foundation; the National Alliance for Research on Schizophrenia and Depression (NARSAD); the Tourette Syndrome Association, Inc; the National Institutes of Health; the Department of Psychiatry of Bellevue Hospital Center; and the New York University School of Medicine, New York, New York. The cooperation of the Health and Hospitals Corporation of the City of New York is gratefully acknowledged.
More on PET Scanning in Autism Spectrum Disorders |
| References |
References
Brasic JR, Holland JA, Alexander M, Rohde CA. The increased likelihood of obstetric complications in autistic disorder [abstract]. Southern Medical Journal. 2006;96 (10 supplement):S34.
Brasic; JR, Holland JA. Reliable classification of case-control studies of autistic disorder and obstetric complications. J of Dev Phys Disabil. 2006;18:355-381.
Brasic JR, Holland JA. A qualitative and quantitative review of obstetric complications and autistic disorder. J of Dev Phys Disabil. 2007;19:337-364.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington, DC:. American Psychiatric Association;2000.
National Center for Health Statistics (NCHS). International Classification of Diseases, Ninth Revision, Clinical Modification, Fourth Edition, 1994 (ICD-9-CM). Los Angeles, Calif:. Practice Management Information Corporation (PMIC);1993.
Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, et al. Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome. Neurology. 2008;70:1313-1321.
Brasic JR. Documentation of demographic data. Psychol Rep. Aug 2003;93(1):151-2. [Medline].
Brasic JR. Documentation of ethnicity. Psychol Rep. Dec 2004;95(3 Pt 1):859-61. [Medline].
Denckla MB. Revised Neurological Examination for Subtle Signs (1985). Psychopharmacol Bull. 1985;21(4):773-800. [Medline].
Chugani HT, Juhász C, Behen ME, Ondersma R, Muzik O. Autism with facial port-wine stain: a new syndrome?. Pediatr Neurol. Sep 2007;37(3):192-9. [Medline].
Chugani DC. Serotonin in autism and pediatric epilepsies. Ment Retard Dev Disabil Res Rev. 2004;10(2):112-6. [Medline].
Chandana SR, Behen ME, Juhasz C, et al. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci. Apr-May 2005;23(2-3):171-82. [Medline].
Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. Jan 2010;67(1):59-68. [Medline].
Wong DF, Brasic JR. In vivo imaging of neurotransmitter systems in neuropsychiatry. Clinical Neuroscience Research. 2001;1:35-45.
Ulay HT, Ertugrul A. [Neuroimaging findings in autism: a brief review]. Turk Psikiyatri Derg. Summer 2009;20(2):164-74. [Medline].
Di Martino A, Ross K, Uddin LQ, Sklar AB, Castellanos FX, Milham MP. Functional brain correlates of social and nonsocial processes in autism spectrum disorders: an activation likelihood estimation meta-analysis. Biol Psychiatry. Jan 1 2009;65(1):63-74. [Medline].
Adolphs R. Social cognition and the human brain. Trends Cogn Sci. Dec 1999;3(12):469-479. [Medline].
Adolphs R, Damasio H, Tranel D, Damasio AR. Cortical systems for the recognition of emotion in facial expressions. J Neurosci. Dec 1 1996;16(23):7678-87. [Medline].
Aronowitz BR, Decaria C, Allen A. The neuropsychiatry of autism and Asperger's disorder: review of the literature and case reports. CNS Spectrums. 1997;2(5):43-55.
Asano E, Chugani DC, Muzik O, et al. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology. Oct 9 2001;57(7):1269-77. [Medline].
Awaad Y, Shamato H, Chugani H. Hemidystonia improved by baclofen and PET scan findings in a patient with glutaric aciduria type I. J Child Neurol. Mar 1996;11(2):167-9. [Medline].
Aylward EH, Minshew NJ, Goldstein G, et al. MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults. Neurology. Dec 10 1999;53(9):2145-50. [Medline].
Azmitia EC. Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology. Aug 1999;21(2 Suppl):33S-45S. [Medline].
Bachevalier J. Medial temporal lobe structures and autism: a review of clinical and experimental findings. Neuropsychologia. Jun 1994;32(6):627-48. [Medline].
Bachevalier J, Mishkin M. Visual recognition impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys. Behav Brain Res. Jun 1986;20(3):249-61. [Medline].
Baron-Cohen S, Ring H, Moriarty J, et al. Recognition of mental state terms. Clinical findings in children with autism and a functional neuroimaging study of normal adults. Br J Psychiatry. Nov 1994;165(5):640-9. [Medline].
Baron-Cohen S, Tager-Flusberg H, Cohen D. Understanding Other Minds. 2nd ed. Oxford, UK: Oxford University Press;1999.
Barrett S, Beck JC, Bernier R, et al. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet. Dec 15 1999;88(6):609-15. [Medline].
Bartlett JC, Searcy J. Inversion and configuration of faces. Cognit Psychol. Jul 1993;25(3):281-316. [Medline].
Bauman M, Kemper TL. Histoanatomic observations of the brain in early infantile autism. Neurology. Jun 1985;35(6):866-74. [Medline].
Bauman ML, Kemper TL. The Neurobiology of Autism and Asperger Syndrome. Baltimore, MD: Johns Hopkins University Press;1994.
Begni B, Molteni M, Nobile M. Studio del trasporto di serotonina nelle piastrine di pazienti in eta evolutiva con disturbi psicopatologici [Serotonin uptake in platelets from child neuropsychiatric patients]. SAGGI Neuropsicologia Infantile Psicopedagogia. 1998;24 (1):13-19.
Berger-Sweeney J, Hohmann CF. Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav Brain Res. Jul 1997;86(2):121-42. [Medline].
Bertolino A, Saunders RC, Mattay VS, et al. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex. Dec 1997;7(8):740-8. [Medline].
Blakely RD, Ramamoorthy S, Schroeter S, et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. Aug 1 1998;44(3):169-78. [Medline].
Boddaert N, Chabane N, Barthelemy C, et al. [Bitemporal lobe dysfonction in infantile autism: positron emission tomography study]. J Radiol. Dec 2002;83(12 Pt 1):1829-33. [Medline].
Bolton PF, Griffiths PD. Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet. Feb 8 1997;349(9049):392-5. [Medline].
Brasic JR. Asperger's Syndrome: A Guide for Parents and Professionals by Tony Attwood, 224 pp., London, Jessica Kingsley Publishers Ltd., 1998 [book review]. Neurology. 1999;52:1112.
Brasic JR. Movements in autistic disorder. Med Hypotheses. Jul 1999;53(1):48-9. [Medline].
Brasic JR. Pervasive Developmental Disorder: Asperger Disorder. eMedicine Pediatric Journal [serial online]. 2006. [Full Text].
Brasic JR. Pervasive Developmental Disorder: Autism. eMedicine Pediatric Journal [serial online]. 2006. [Full Text].
Braverman M, Fein D, Lucci D, Waterhouse L. Affect comprehension in children with pervasive developmental disorders. J Autism Dev Disord. Jun 1989;19(2):301-16. [Medline].
Brett EM. Paediatric Neurology, Second Edition. Edinburgh, London: Churchill Livingstone;1991.
Brown CM, Fletcher PJ, Coscina DV. Acute amino acid loads that deplete brain serotonin fail to alter behavior. Pharmacol Biochem Behav. Jan 1998;59(1):115-21. [Medline].
Buchsbaum MS, Siegel BV, Wu JC, et al. Brief report: attention performance in autism and regional brain metabolic rate assessed by positron emission tomography. J Autism Dev Disord. Mar 1992;22(1):115-25. [Medline].
Butter CM. Impairments in selective attention to visual stimuli in monkeys with inferotemporal and lateral striate lesions. Brain Res. Feb 1969;12(2):374-83. [Medline].
Calder AJ, Lawrence AD, Keane J, et al. Reading the mind from eye gaze. Neuropsychologia. 2002;40(8):1129-38. [Medline].
Caplan R, Curtiss S, Chugani HT, Vinters HV. Pediatric Rasmussen encephalitis: social communication, language, PET and pathology before and after hemispherectomy. Brain Cogn. Oct 1996;32(1):45-66. [Medline].
Carlsson A, Waters N, Carlsson ML. Neurotransmitter interactions in schizophrenia--therapeutic implications. Biol Psychiatry. Nov 15 1999;46(10):1388-95. [Medline].
Carlsson ML. Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy. J Neural Transm. 1998;105(4-5):525-35. [Medline].
Carlsson ML, Martin P, Nilsson M, et al. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice. J Neural Transm. 1999;106(2):123-9. [Medline].
Carmichael ST. Hunger and the temporal lobe. Neurology. May 1995;45(5):1026-7. [Medline].
Carmichael ST, Price JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol. Dec 25 1995;363(4):615-641. [Medline].
Carmichael ST, Price JL. Sensory and premotor connections of the orbital and medial prefrontal cortex of macaque monkeys. J Comp Neurol. Dec 25 1995;363(4):642-664. [Medline].
Carter CS. Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology. Nov 1998;23(8):779-818. [Medline].
Cartwright C, Hollander E. SSRIs in the treatment of obsessive-compulsive disorder. Depress Anxiety. 1998;8 Suppl 1:105-13. [Medline].
Castelli F, Frith C, Happe F, Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes. Brain. Aug 2002;125(Pt 8):1839-49. [Medline].
Chakraborty PK, Mangner TJ, Chugani DC, et al. A high-yield and simplified procedure for the synthesis of alpha-[11C]methyl-L-tryptophan. Nucl Med Biol. Nov 1996;23(8):1005-8. [Medline].
Chao LL, Haxby JV, Martin A. Attribute-based neural substrates in temporal cortex for perceiving and knowing about objects. Nat Neurosci. Oct 1999;2(10):913-9. [Medline].
Chao LL, Martin A, Haxby JV. Are face-responsive regions selective only for faces?. Neuroreport. Sep 29 1999;10(14):2945-50. [Medline].
Cho R, Kapur S, Du L, Hrdina P. Relationship between central and peripheral serotonin 5-HT2A receptors: a positron emission tomography study in healthy individuals. Neurosci Lett. Feb 19 1999;261(3):139-42. [Medline].
Chugani DC. Role of altered brain serotonin mechanisms in autism. Mol Psychiatry. 2002;7 Suppl 2:S16-7. [Medline].
Chugani DC, Muzik O, Behen M. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol. Mar 1999;45(3):287-95. [Medline].
Chugani DC, Muzik O, Chakraborty P, et al. Human brain serotonin synthesis capacity measured in vivo with alpha-[C-11]methyl-L-tryptophan. Synapse. Jan 1998;28(1):33-43. [Medline].
Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol. Oct 1997;42(4):666-9. [Medline].
Chugani DC, Sundram BS, Behen M, et al. Evidence of altered energy metabolism in autistic children. Prog Neuropsychopharmacol Biol Psychiatry. May 1999;23(4):635-41. [Medline].
Chugani HT, Conti JR. Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol. Jan 1996;11(1):44-8. [Medline].
Chugani HT, Da Silva E, Chugani DC. Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol. May 1996;39(5):643-9. [Medline].
Chugani HT, Muller RA, Chugani DC. Functional brain reorganization in children. Brain Dev. Sep-Oct 1996;18(5):347-56. [Medline].
Conrad B. [Tic/Tourette's syndrome]. Klinische Neurophysiologie. 1999;30 (2):90-95.
Cook EH, Charak DA, Arida J, et al. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res. Apr 1994;52(1):25-33. [Medline].
Cook EH, Stein MA, Ellison T, et al. Attention deficit hyperactivity disorder and whole-blood serotonin levels: effects of comorbidity. Psychiatry Res. Jun 29 1995;57(1):13-20. [Medline].
Courchesne E, Muller RA, Saitoh O. Brain weight in autism: normal in the majority of cases, megalencephalic in rare cases. Neurology. Mar 23 1999;52(5):1057-9. [Medline].
Courchesne E, Press GA, Yeung-Courchesne R. Parietal lobe abnormalities detected with MR in patients with infantile autism. AJR Am J Roentgenol. Feb 1993;160(2):387-93. [Medline].
Critchley HD, Daly EM, Bullmore ET, et al. The functional neuroanatomy of social behaviour: changes in cerebral blood flow when people with autistic disorder process facial expressions. Brain. Nov 2000;123 (Pt 11):2203-12. [Medline].
D'Eufemia P, Finocchiaro R, Celli M, et al. Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism. Biomed Pharmacother. 1995;49(6):288-92. [Medline].
D'Souza DC, Berman RM, Krystal JH, Charney DS. Symptom provocation studies in psychiatric disorders: scientific value, risks, and future. Biol Psychiatry. Oct 15 1999;46(8):1060-80. [Medline].
da Silva EA, Chugani DC, Muzik O, Chugani HT. Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia. Nov 1997;38(11):1198-208. [Medline].
da Silva EA, Chugani DC, Muzik O, Chugani HT. Landau-Kleffner syndrome: metabolic abnormalities in temporal lobe are a common feature. J Child Neurol. Nov 1997;12(8):489-95. [Medline].
Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci. Oct 29 1996;351(1346):1413-20. [Medline].
Davies S, Bishop D, Manstead AS, Tantam D. Face perception in children with autism and Asperger's syndrome. J Child Psychol Psychiatry. Sep 1994;35(6):1033-57. [Medline].
Deb S, Thompson B. Neuroimaging in autism. Br J Psychiatry. Oct 1998;173:299-302. [Medline].
Delbeke D, Lawrence SK, Abou-Khalil BW, et al. Postsurgical outcome of patients with uncontrolled complex partial seizures and temporal lobe hypometabolism on 18FDG-positron emission tomography. Invest Radiol. May 1996;31(5):261-6. [Medline].
DeLong GR. Autism: new data suggest a new hypothesis. Neurology. Mar 23 1999;52(5):911-6. [Medline].
Diamond R, Carey S. Why faces are and are not special: an effect of expertise. J Exp Psychol Gen. Jun 1986;115(2):107-17. [Medline].
Diomedi M, Curatolo P, Scalise A, et al. Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects. Brain Dev. Dec 1999;21(8):548-53. [Medline].
Egaas B, Courchesne E, Saitoh O. Reduced size of corpus callosum in autism. Arch Neurol. Aug 1995;52(8):794-801. [Medline].
Ernst M, Zametkin AJ, Matochik JA, et al. Low medial prefrontal dopaminergic activity in autistic children. Lancet. Aug 30 1997;350(9078):638. [Medline].
Espert R, Navarro JF. Correlatos biologicos del sindrome de Gilles de la Tourette [Biological correlates of the syndrome of Gilles de la Tourette]. Psicologia Conductual. 1998;6 (2):411-433.
Farah MJ. Is face recognition 'special'? Evidence from neuropsychology. Behav Brain Res. Apr 1996;76(1-2):181-9. [Medline].
Fein D, Lucci D, Braverman M, Waterhouse L. Comprehension of affect in context in children with pervasive developmental disorders. J Child Psychol Psychiatry. Oct 1992;33(7):1157-67. [Medline].
Feng D, Huang SC, Wang X. Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. Int J Biomed Comput. Mar 1993;32(2):95-110. [Medline].
Feng D, Wang X. A computer simulation study on the effects of input function measurement noise in tracer kinetic modeling with positron emission tomography (PET). Comput Biol Med. Jan 1993;23(1):57-68. [Medline].
Fernell E, Watanabe Y, Adolfsson I, et al. Possible effects of tetrahydrobiopterin treatment in six children with autism--clinical and positron emission tomography data: a pilot study. Dev Med Child Neurol. May 1997;39(5):313-8. [Medline].
Ferrarese C, Cogliati T, Tortorella R, et al. Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res. Jan 1998;29(2):129-34. [Medline].
Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. Dec 1999;29(6):439-84. [Medline].
Filipek PA, Accardo PJ, Baranek GT, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord. Dec 1999;29(6):439-84. [Medline].
Fisher E, Van Dyke DC, Sears L. Recent research on the etiologies of autism. Infants and Young Children. January 1999;11 (3):1-8.
Fletcher PC, Happe F, Frith U, et al. Other minds in the brain: a functional imaging study of "theory of mind" in story comprehension. Cognition. Nov 1995;57(2):109-28. [Medline].
Fombonne E. Autism: recent research findings. Current Opinion in Psychiatry. September 1997;10 (5):373-377.
Fombonne E, Bolton P, Prior J, et al. A family study of autism: cognitive patterns and levels in parents and siblings. J Child Psychol Psychiatry. Sep 1997;38(6):667-83. [Medline].
Fost JW. Neural rhymicity, feature binding, and serotonin: a hypothesis. Neuroscientist. March 1999;5 (2):79-85.
Fowler CJ, Sjoberg E, Tiger G. Serotonin stimulation of calcium mobilisation in human platelets: choice of units of measurement, effects of age and tobacco use, and correlation with serotonin2A receptor density. Clin Chim Acta. Sep 1999;287(1-2):1-18. [Medline].
Gauthier I, Behrmann M, Tarr MJ. Can face recognition really be dissociated from object recognition?. J Cogn Neurosci. Jul 1999;11(4):349-70. [Medline].
Gauthier I, Tarr MJ. Becoming a "Greeble" expert: exploring mechanisms for face recognition. Vision Res. Jun 1997;37(12):1673-82. [Medline].
Gauthier I, Tarr MJ, Anderson AW, et al. Activation of the middle fusiform 'face area' increases with expertise in recognizing novel objects. Nat Neurosci. Jun 1999;2(6):568-73. [Medline].
Gazzaniga MS. The Cognitive Neurosciences. Cambridge, MA: The MIT Press;1995.
Gillberg C. Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J Autism Dev Disord. Sep 1986;16(3):369-75. [Medline].
Gillberg C, Coleman M. The Biology of the Autistic Syndromes, 3rd edition. Clinics in Developmental Medicine Number 153/4. London, UK: Mac Keith Press;2000.
Gillberg IC. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism. Dev Med Child Neurol. Oct 1991;33(10):920-4. [Medline].
Goel V, Grafman J, Sadato N, Hallett M. Modeling other minds. Neuroreport. Sep 11 1995;6(13):1741-6. [Medline].
Goldberg J, Szatmari P, Nahmias C. Imaging of autism: lessons from the past to guide studies in the future. Can J Psychiatry. Oct 1999;44(8):793-801. [Medline].
Gordon I. Cerebral imaging in paediatrics. Q J Nucl Med. Jun 1998;42(2):126-32. [Medline].
Hamann SB, Stefanacci L, Squire LR, et al. Recognizing facial emotion. Nature. Feb 8 1996;379(6565):497. [Medline].
Happe F, Ehlers S, Fletcher P, et al. 'Theory of mind' in the brain. Evidence from a PET scan study of Asperger syndrome. Neuroreport. Dec 20 1996;8(1):197-201. [Medline].
Happe F, Frith U. The neuropsychology of autism. Brain. Aug 1996;119 (Pt 4):1377-400. [Medline].
Happe FG. Studying weak central coherence at low levels: children with autism do not succumb to visual illusions. A research note. J Child Psychol Psychiatry. Oct 1996;37(7):873-7. [Medline].
Hardan AY, Minshew NJ, Keshavan MS. Corpus callosum size in autism. Neurology. Oct 10 2000;55(7):1033-6. [Medline].
Harris JC. Developmental Neuropsychiatry: Volume II: Assessment, Diagnosis, and Treatment of Developmental Disorders. New York and Oxford: Oxford University Press;1995.
Harris NS, Courchesne E, Townsend J, et al. Neuroanatomic contributions to slowed orienting of attention in children with autism. Brain Res Cogn Brain Res. May 1999;8(1):61-71. [Medline].
Harrison JE, Bolton PF. Annotation: tuberous sclerosis. J Child Psychol Psychiatry. Sep 1997;38(6):603-14. [Medline].
Harteveld EM, Buitelaar JK. Autism: role of drug treatment and a guide to its use. CNS Drugs. September 8 1997;8 (3):227-236.
Hauck M, Fein D, Maltby N. Memory for faces in children with autism and Asperger syndrome. Child Neuropsychology. 1998;4:187-198.
Haxby JV, Grady CL, Horwitz B, et al. Dissociation of object and spatial visual processing pathways in human extrastriate cortex. Proc Natl Acad Sci U S A. Mar 1 1991;88(5):1621-5. [Medline].
Haxby JV, Ungerleider LG, Clark VP, et al. The effect of face inversion on activity in human neural systems for face and object perception. Neuron. Jan 1999;22(1):189-99. [Medline].
Haznedar MM, Buchsbaum MS, Metzger M, et al. Anterior cingulate gyrus volume and glucose metabolism in autistic disorder. Am J Psychiatry. Aug 1997;154(8):1047-50. [Medline].
Haznedar MM, Buchsbaum MS, Wei TC, et al. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am J Psychiatry. Dec 2000;157(12):1994-2001. [Medline].
Heh CW, Smith R, Wu J, et al. Positron emission tomography of the cerebellum in autism. Am J Psychiatry. Feb 1989;146(2):242-5. [Medline].
Herault J, Petit E, Martineau J, et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Res. Nov 1 1996;65(1):33-43. [Medline].
Hesselink JMK, Sambunaris A. Behavioral pharmacology of serotonin receptor subtypes: hypotheses for clinical applications of selective serotonin ligands. International Review of Psychiatry. 1995;7:41-53.
Hobson RP. The autistic child's appraisal of expressions of emotion. J Child Psychol Psychiatry. May 1986;27(3):321-42. [Medline].
Hobson RP. The autistic child's appraisal of expressions of emotion: a further study. J Child Psychol Psychiatry. Sep 1986;27(5):671-80. [Medline].
Hobson RP, Lee A. Emotion-related and abstract concepts in autistic people: evidence from the British Picture Vocabulary Scale. J Autism Dev Disord. Dec 1989;19(4):601-23. [Medline].
Hobson RP, Ouston J, Lee A. Emotion recognition in autism: coordinating faces and voices. Psychol Med. Nov 1988;18(4):911-23. [Medline].
Hobson RP, Ouston J, Lee A. What's in a face? The case of autism. Br J Psychol. Nov 1988;79 (Pt 4):441-53. [Medline].
Hoh CK, Dahlbom M, Harris G, et al. Automated iterative three-dimensional registration of positron emission tomography images. J Nucl Med. Nov 1993;34(11):2009-18. [Medline].
Hol T, Van den Berg CL, Van Ree JM, et al. Isolation during the play period in infancy decreases adult social interactions in rats. Behav Brain Res. Apr 1999;100(1-2):91-7. [Medline].
Hollander E. Autism Spectrum Disorders. 24 of the Medical Psychiatry Series. New York, NY: Marcel Dekker Inc;2003.
Hollander E. Treatment of obsessive-compulsive spectrum disorders with SSRIs. Br J Psychiatry Suppl. 1998;7-12. [Medline].
Hollander E, Novotny S, Allen A. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology. Feb 2000;22(2):163-7. [Medline].
Hoon AH, Reiss AL. The mesial-temporal lobe and autism: case report and review. Dev Med Child Neurol. Mar 1992;34(3):252-9. [Medline].
Hutt C, Ounsted C. The biological significance of gaze aversion with particular reference to the syndrome of infantile autism. Behav Sci. Sep 1966;11(5):346-56. [Medline].
Insel TR, O'Brien DJ, Leckman JF. Oxytocin, vasopressin, and autism: is there a connection?. Biol Psychiatry. Jan 15 1999;45(2):145-57. [Medline].
Insel TR, Winslow JT. Serotonin and neuropeptides in affiliative behaviors. Biol Psychiatry. Aug 1 1998;44(3):207-19. [Medline].
Ishai A, Ungerleider LG, Martin A, et al. Distributed representation of objects in the human ventral visual pathway. Proc Natl Acad Sci U S A. Aug 3 1999;96(16):9379-84. [Medline].
Jambaque I, Mottron L, Ponsot G, Chiron C. Autism and visual agnosia in a child with right occipital lobectomy. J Neurol Neurosurg Psychiatry. Oct 1998;65(4):555-60. [Medline].
Kanwisher N, McDermott J, Chun MM. The fusiform face area: a module in human extrastriate cortex specialized for face perception. J Neurosci. Jun 1 1997;17(11):4302-11. [Medline].
Kimberg DY, Farah MJ. A unified account of cognitive impairments following frontal lobe damage: the role of working memory in complex, organized behavior. J Exp Psychol Gen. Dec 1993;122(4):411-28. [Medline].
Klauck SM, Poustka F, Benner A, et al. Serotonin transporter (5-HTT) gene variants associated with autism?. Hum Mol Genet. Dec 1997;6(13):2233-8. [Medline].
Langdell T. Recognition of faces: an approach to the study of autism. J Child Psychol Psychiatry. Jul 1978;19(3):255-68. [Medline].
Lassig JP, Vachirasomtoon K, Hartzell K, et al. Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder. Am J Med Genet. Oct 15 1999;88(5):472-5. [Medline].
Leboyer M, Philippe A, Bouvard M, et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry. Jan 15 1999;45(2):158-63. [Medline].
LeDoux JE. The Emotional Brain: The Mysterious Underpinnings of Emotional Life. Simon and Schuster, New York, NY. 1996.
Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?. Biol Psychiatry. Aug 1 1998;44(3):179-92. [Medline].
Leventhal BL, Cook EH, Lord C. The irony of autism. Arch Gen Psychiatry. Jul 1998;55(7):643-4. [Medline].
Longhurst JG, Potenza MN, McDougle CJ. Autism. N Engl J Med. Nov 20 1997;337(21):1555-6; author reply 1556-7.
Macdonald H, Rutter M, Howlin P, et al. Recognition and expression of emotional cues by autistic and normal adults. J Child Psychol Psychiatry. Nov 1989;30(6):865-77. [Medline].
Maestrini E, Lai C, Marlow A, et al. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet. Oct 15 1999;88(5):492-6. [Medline].
Martin A, Scahill L, Klin A, Volkmar FR. Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use. J Am Acad Child Adolesc Psychiatry. Jul 1999;38(7):923-31. [Medline].
McBride PA, Anderson GM, Hertzig ME, et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry. Jul 1998;37(7):767-76. [Medline].
McBride PA, Anderson GM, Shapiro T. Autism research. Bringing together approaches to pull apart the disorder. Arch Gen Psychiatry. Nov 1996;53(11):980-3. [Medline].
McDougle CJ, Naylor ST, Cohen DJ, et al. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry. Nov 1996;53(11):1001-8. [Medline].
McDougle CJ, Naylor ST, Cohen DJ, et al. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry. Nov 1996;53(11):993-1000. [Medline].
McKelvey JR, Lambert R, Mottron L, Shevell MI. Right-hemisphere dysfunction in Asperger's syndrome. J Child Neurol. Jul 1995;10(4):310-4. [Medline].
Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev. Dec 1999;23(8):1111-25. [Medline].
Menzies V, Farrell SP. Schizophrenia, tardive dyskinesia, and the Abnormal Involuntary Movement Scale (AIMS). J Am Psychiatr Nurses Assoc. 2002;8:51-56.
Messahel S, Pheasant AE, Pall H, et al. Urinary levels of neopterin and biopterin in autism. Neurosci Lett. Jan 23 1998;241(1):17-20. [Medline].
Middleton FA, Strick PL. Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function. Science. Oct 21 1994;266(5184):458-61. [Medline].
Minshew NJ, Luna B, Sweeney JA. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Neurology. Mar 23 1999;52(5):917-22. [Medline].
Mohanty S, Steinbusch HW, Ganguly DK, Mohanakumar KP. Behavioral and neurochemical alterations following intracerebroventricular administration of anti-serotonin antibodies in adult Balb/c mice. J Chem Neuroanat. Jun 1998;14(3-4):141-9. [Medline].
Molteni M, Zulian C, Scrofani S, et al. High frequency of T-cell lines responsive to immunodominant epitopes of thyrotropin receptor in healthy subjects. Thyroid. Mar 1998;8(3):241-7. [Medline].
Morgan MA, Romanski LM, LeDoux JE. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett. Nov 26 1993;163(1):109-13. [Medline].
Moscovitch M, Winocur G, Behrmann M. What is special about face recognition? Nineteen experiments on a person with visual object agnosia and dyslexia but normal face recognition. J Cogn Neurosci. 1997;9:555-604.
Mountz JM, Tolbert LC, Lill DW, et al. Functional deficits in autistic disorder: characterization by technetium-99m-HMPAO and SPECT. J Nucl Med. Jul 1995;36(7):1156-62. [Medline].
Muller RA, Behen ME, Rothermel RD, et al. Brain mapping of language and auditory perception in high-functioning autistic adults: a PET study. J Autism Dev Disord. Feb 1999;29(1):19-31. [Medline].
Muller RA, Chugani DC, Behen ME, et al. Impairment of dentato-thalamo-cortical pathway in autistic men: language activation data from positron emission tomography. Neurosci Lett. Mar 27 1998;245(1):1-4. [Medline].
Muller RA, Rothermel RD, Behen ME. Language organization in patients with early and late left-hemisphere lesion: a PET study. Neuropsychologia. May 1999;37(5):545-57. [Medline].
Muller RA, Rothermel RD, Behen ME, et al. Language organization in patients with early and late left-hemisphere lesion: a PET study. Neuropsychologia. May 1999;37(5):545-57. [Medline].
Muzik O, Chugani DC, Chakraborty P, et al. Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab. Jun 1997;17(6):659-69. [Medline].
Nahas Z, George MS, Lorberbaum JP. SPECT and PET in neuropsychiatry. Primary Psychiatry. 1998;5 (3):52-59.
Nelson EE, Panksepp J. Brain substrates of infant-mother attachment: contributions of opioids, oxytocin, and norepinephrine. Neurosci Biobehav Rev. May 1998;22(3):437-52. [Medline].
Okado N. [Mechanisms for formation and maintenance of synapses mediated by biogenic amines: pathogenesis and therapy of mental retardation and developmental disabilities by genetic and epigenetic factors]. Kaibogaku Zasshi. Jun 1999;74(3):351-62. [Medline].
Ono T, Nishijo H, Uwano T. Amygdala role in conditioned associative learning. Prog Neurobiol. Jul 1995;46(4):401-22. [Medline].
Pasqualetti M, Ori M, Marazziti D. Distribution of 5-HT2c and 5-ht5a receptor mRNA in human brain. Ann N Y Acad Sci. Dec 15 1998;861:245. [Medline].
Pasqualetti M, Ori M, Nardi I, et al. Distribution of the 5-HT5A serotonin receptor mRNA in the human brain. Brain Res Mol Brain Res. May 1998;56(1-2):1-8. [Medline].
Peacock WJ, Wehby-Grant MC, Shields WD, et al. Hemispherectomy for intractable seizures in children: a report of 58 cases. Childs Nerv Syst. Jul 1996;12(7):376-84. [Medline].
Pedersen OS, Liu Y, Reichelt KL. Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines. J Pept Res. Jun 1999;53(6):641-6. [Medline].
Peterson BS, Leckman JF, Tucker D, et al. Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders. Arch Gen Psychiatry. Apr 2000;57(4):364-72. [Medline].
Petit E, Herault J, Raynaud M, et al. X chromosome and infantile autism. Biol Psychiatry. Sep 15 1996;40(6):457-64. [Medline].
Plum F, Mountcastle V, Geiger S. Handbook of Physiology: The Nervous System. Bethesda, MD: American Physiological Association;1987.
Potenza MN, Holmes JP, Kanes SJ, McDougle CJ. Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. J Clin Psychopharmacol. Feb 1999;19(1):37-44. [Medline].
Potenza MN, McDougle CJ. The role of serotonin in autism-spectrum disorders. CNS Spectrums. 1997;2 (5):25-42.
Price JL, Carmichael ST, Drevets WC. Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior?. Prog Brain Res. 1996;107:523-36. [Medline].
Puce A, Allison T, Bentin S, et al. Temporal cortex activation in humans viewing eye and mouth movements. J Neurosci. Mar 15 1998;18(6):2188-99. [Medline].
Rapin I. Appropriate investigations for clinical care versus research in children with autism. Brain Dev. Apr 1999;21(3):152-6. [Medline].
Rapin I. Autism in search of a home in the brain. Neurology. Mar 23 1999;52(5):902-4. [Medline].
Rapin I. The International Child Neurology Association: the first 25 years. Brain Dev. Jan 1999;21(1):3-15. [Medline].
Rapoport JL. Child psychiatry comes of age: growing sophistication, evolving strategies. Am J Psychiatry. Aug 1997;154(8):1043-5. [Medline].
Rubenstein JL. Development of serotonergic neurons and their projections. Biol Psychiatry. Aug 1 1998;44(3):145-50. [Medline].
Rumsey JM, Ernst M. Functional neuroimaging of autistic disorders. Ment Retard Dev Disabil Res Rev. 2000;6(3):171-9. [Medline].
Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR. Neonatal lesions of the medial temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature. May 14 1998;393(6681):169-71. [Medline].
Scahill L, Koenig K. Pharmacotherapy in children and adolescents with pervasive developmental disorders. J Child Adolesc Psychiatr Nurs. Jan-Mar 1999;12(1):41-3. [Medline].
Schain RJ, Freedman DX. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr. Mar 1961;58:315-20. [Medline].
Schifter T, Hoffman JM, Hatten HP, et al. Neuroimaging in infantile autism. J Child Neurol. Apr 1994;9(2):155-61. [Medline].
Schmahmann JD. Dysmetria of thought: clinical consequences of cerebellar dysfunction on cognition and affect. Trends Cogn Sci. Sept 1 1998;2(9):362-371.
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. Apr 1998;121 (Pt 4):561-79. [Medline].
Schultz RT, Gauthier I, Klin A, et al. Abnormal ventral temporal cortical activity during face discrimination among individuals with autism and Asperger syndrome. Arch Gen Psychiatry. Apr 2000;57(4):331-40. [Medline].
Schultz RT, Romanski L, Tsatsanis K. Neurofunctional models of autistic disorder and Asperger syndrome: clues from neuroimaging. Asperger Syndrome. Guilford, New York. 2000:172-209.
Sears LL, Vest C, Mohamed S, et al. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry. May 1999;23(4):613-24. [Medline].
Shamoto H, Chugani DC, Chugani HT. Glucose metabolism in the human cerebellum: anatomical-functional correlations. J Child Neurol. Nov 1996;11(6):451-7. [Medline].
Shoaf SE, Carson RE, Hommer D, et al. The suitability of [11C]-alpha-methyl-L-tryptophan as a tracer for serotonin synthesis: studies with dual administration of [11C] and [14C] labeled tracer. J Cereb Blood Flow Metab. Feb 2000;20(2):244-52. [Medline].
Siegel BV, Asarnow R, Tanguay P, et al. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism. J Neuropsychiatry Clin Neurosci. 1992;4(4):406-14. [Medline].
Siegel BV, Nuechterlein KH, Abel L, et al. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophr Res. Sep 1995;17(1):85-94. [Medline].
Singh VK, Singh EA, Warren RP. Hyperserotoninemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol Psychiatry. Mar 15 1997;41(6):753-5. [Medline].
Skjeldal OH, Sponheim E, Ganes T, et al. Childhood autism: the need for physical investigations. Brain Dev. Jun 1998;20(4):227-33. [Medline].
Steffenburg S, Gillberg C. Autism and autistic-like conditions in Swedish rural and urban areas: a population study. Br J Psychiatry. Jul 1986;149:81-7. [Medline].
Stip E, Lecours AR, O'Connor K. La coprolalie dans la maladie de Gilles de la Tourette: epreuve de decision lexicale [Corpolalia in the disease of Gilles de la Tourette: a task of lexical decision]. Revue de Neuropsychologie. 1999;9 (1):43-59.
Stone VE, Baron-Cohen S, Knight RT. Frontal lobe contributions to theory of mind. J Cogn Neurosci. Sep 1998;10(5):640-56. [Medline].
Stuss DT, Benson D. The Frontal Lobes. New York, NY: Raven Press;1986.
Tanaka JW, Farah MJ. Parts and wholes in face recognition. Q J Exp Psychol A. May 1993;46(2):225-45. [Medline].
Tantam D, Monaghan L, Nicholson H, Stirling J. Autistic children's ability to interpret faces: a research note. J Child Psychol Psychiatry. Jul 1989;30(4):623-30. [Medline].
Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci. Mar 1999;24(2):103-15. [Medline].
Tsai LY. Psychopharmacology in autism. Psychosom Med. Sep-Oct 1999;61(5):651-65. [Medline].
Turner C, Panksepp J, Bekkedal M, et al. Paradoxical effects of serotonin and opioids in pemoline-induced self-injurious behavior. Pharmacol Biochem Behav. Jul 1999;63(3):361-6. [Medline].
Valentine T. Upside-down faces: a review of the effect of inversion upon face recognition. Br J Psychol. Nov 1988;79 (Pt 4):471-91. [Medline].
Valentine T, Bruce V. Mental rotation of faces. Mem Cognit. Nov 1988;16(6):556-66. [Medline].
Venkatesh S, Coulter DL, Kemper TD. Neuroaxonal dystrophy at birth with hypertonicity and basal ganglia mineralization. J Child Neurol. Jan 1994;9(1):74-6. [Medline].
Verdot L, Garreau B, Barthelemy C, et al. Immunoreactivity of sera to a peptide derived from the serotonin 5-HT1A receptor in a group of children with developmental disorders: possible role in non-autistic epilepsy. Int J Mol Med. Jan 1998;1(1):185-9. [Medline].
Volkmar FR, Klin A, Schultz RT, et al. Asperger's disorder. Am J Psychiatry. Feb 2000;157(2):262-7. [Medline].
Webster MJ, Ungerleider LG, Bachevalier J. Lesions of inferior temporal area TE in infant monkeys alter cortico-amygdalar projections. Neuroreport. Dec 1991;2(12):769-72. [Medline].
Weeks SJ, Hobson RP. The salience of facial expression for autistic children. J Child Psychol Psychiatry. Jan 1987;28(1):137-51. [Medline].
Wong DF, Harris JC, Naidu S, et al. Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proc Natl Acad Sci U S A. May 28 1996;93(11):5539-43. [Medline].
Wong DF, Ricaurte G, Grunder G, et al. Dopamine transporter changes in neuropsychiatric disorders. Adv Pharmacol. 1998;42:219-23. [Medline].
Young JG, Brasic JR, Ostrer H. The developing brain and mind: advances in research techniques. In: Lewis M, ed. Child and Adolescent Psychiatry: A Comprehensive Textbook. 2nd ed. 1996;1209-1234. [Medline].
Zilbovicius M, Boddaert N, Belin P, et al. Temporal lobe dysfunction in childhood autism: a PET study. Positron emission tomography. Am J Psychiatry. Dec 2000;157(12):1988-93. [Medline].
Further Reading
Keywords
autistic disorder, positron emission tomography, PET, Asperger disorder, Rett disorder, childhood disintegrative disorder, pervasive developmental disorders, autism, tuberous sclerosis, serotonin abnormalities, electroencephalogram, neurometric electrophysiological evaluation, Asperger syndrome, autism spectrum disorders
